About Andy Expertise Healthcare & Life Sciences Mergers and Acquisitions Performance Improvement Spin-offs Recent Insights “Front Line of Healthcare Report 2017: Why involving doctors can help improve US healthcare,” Report, May 2017 “Category Focus Rewards Biopharma Shareholders,” In Vivo, February 2017, Article “Focus Matters: How Biopharma Can Reward Shareholders,” Brief, November 2016 “Fate of cost-saving biosimilar drugs may hinge on naming policy,” Modern Healthcare, July 2015 “Sometimes Companies Need to Break Up Too. Is It Time for to Split Up?,” Jakarta Globe, June 2015, Article